UE LifeSciences raises $3M from Aarin, Unitus

15 September, 2015

UE LifeSciences Inc, a health technology developer, has raised $3 million (Rs 20 crore) in its Series A round of funding led by Aarin Capital, a venture capital firm co-founded by Manipal Group’s Ranjan Pai and former Infosys director TV Mohandas Pai (not related).

The company will use the money to expand trials of its newly developed hand-held breast health examination device called ‘iBreastExam’ in India. It will also look to set up its manufacturing units and build distribution networks through public and private primary care providers across the country, it said.

Unitus Seed Fund, an India-focused early stage investor, also participated in this round.

“We are excited to partner with Aarin Capital and Unitus Seed Fund to bring this product to scale in India and other markets where breast cancer is commonly detected at later stages,” Mihir Shah, founder and CEO of UE LifeSciences, said.

An alumni of Drexel University, Shah claims that its device ‘iBreastExam’ is an early indication test like blood pressure monitor, glucometer or pulse oximeter and help detect suspicious lumps and lesions in the breast at an early stage.

He said the US-based firm is targeting 190 million women in India who can benefit from regular breast health checks.

“iBreastExam brings high quality breast health examination to lakhs of Indian women, who hitherto did not have access to any such kind of diagnostics. This has the potential to save millions of women’s lives,” Ranjan Pai, who is the managing director and CEO of Manipal Education and Medical Group (MEMG), said.

Aarin Capital puts money in mid-stage startups through the $100 million Aarin Capital Fund I. The firm seeks to invest between $3 million and $10 million in life sciences, technology and internet sector. It has recently put money as part of a $2 million round in local services marketplace Zimmber. It also has positions in EdCast, KleverKid and HomeLane.

“We see UE LifeSciences’ iBreastExam device as a disruptive opportunity, given the strong need for primary health check for breast, lack of viable alternatives and lack of highly skilled healthcare resources in India,” said Dave Richards, managing partner, Unitus Seed Fund.

Unitus Seed Fund is part of the Unitus Group, a financial services group operating in India and other emerging markets since 2000. It has offices in Bangalore and Seattle (the US). To date, the company has made around 20 investments in India across sectors such as healthcare, education, mobile, e-commerce, retail and agriculture through its $23 million seed fund.

Leave Your Comment
UE LifeSciences gets follow-on funding from Biocon's Kiran Mazumdar-Shaw

UE LifeSciences gets follow-on funding from Biocon’s Kiran Mazumdar-Shaw

Joseph Rai 11 months ago
UE LifeSciences Inc, a health technology firm that develops breast cancer screening devices, has raised a follow-on funding worth $1.2 million from Kiran Mazumdar-Shaw, chairperson...
Unitus invests in medical diagnostics device maker UE LifeSciences

Unitus invests in medical diagnostics device maker UE LifeSciences

Jasleen Kaur Batra 2 years ago
India-focused early-stage investor Unitus Seed Fund has picked UE LifeSciences Inc, a US- and India-based portable breast screening device maker, as the second startup under...
Unitus enhances corpus of StartHealth

Unitus enhances corpus of StartHealth

Anuradha Verma 2 years ago
India-focused early stage investor Unitus Seed Fund has roped in Ashwin Naik, founder of Bangalore-based Vaatsalya Healthcare Solutions Pvt Ltd, as healthcare fund advisor as...
No Comments

UE LifeSciences raises $3M from Aarin, Unitus

Powered by WordPress.com VIP